Close Menu

Clostridium difficile

SlipChip

New micro-device is inexpensive to manufacture and can run nucleic acid amplification at room temperature.

NEW YORK (GenomeWeb) — Molecular diagnostics firm Great Basin Scientific has priced a planned initial public offering of 1.15 million units, with each unit consisting of one share of common stock and one Series A warrant.

Germany's MoBiTec said this week announced the availability of the EBOV real time RT-PCR kit for the detection of Ebola virus.

NEW YORK (GenomeWeb) — IMDx said today that it has received three additional licenses for sale and distribution of its molecular tests for the Abbott m2000 platform outside the US and EU.

NEW YORK (GenomeWeb) – Enterome and Synthetic Biologics will conduct microbiome research on the effects of beta-lactam antibiotics on humans as part of an agreement announced today.

NEW YORK (GenomeWeb) — Qiagen has achieved a major milestone in its efforts to expand uptake of its QIAsymphony RGQ molecular diagnostics system, as the company disclosed this week that the platform recently received 510(k) clearance from the US Food and Drug Administration.

NEW YORK (GenomeWeb) — Qiagen has received 510(k) clearance from the US Food and Drug Administration for its QIAsymphony RGQ MDx system and Artus C. difficile QS-RGQ MDx kit, the company said Monday after the close of the market.

Roche's acquisition of privately held Boston-area molecular diagnostics developer Iquum, announced earlier this week, is expected to fill a hole in Roche's product portfolio, gi

NEW YORK (GenomeWeb News) – For the past eight years Menon Biosensors has operated in near secrecy developing a technology with US government backing to detect some of the world's deadliest biothreat pathogens.

As one of its major molecular diagnostics-related revenue sources begins to slow down, Qiagen today outlined its plan to replace it with several new MDx initiatives and other molecular biology-related growth drivers.

Pages

Google's Project Nightingale has collected health information on millions of Americans, according to the Wall Street Journal.

An opinion piece at The Hill criticizes the proposed plan to collect DNA samples from migrants at the US border.

Nature News writes that women in chemistry are less likely to have their manuscripts accepted for publication.

In PNAS this week: tRNA fragment signature for chronic lymphocytic leukemia, genomic sites sensitive to ultraviolet radiation in melanocytes, and more.